Nonpeptide angiotensin II receptor antagonists

Trends in Pharmacological Sciences
P B TimmermansW F Herblin


Substantial progress has been made recently in the development of nonpeptide angiotensin II receptor antagonists, a goal that has long remained an unmet challenge. Pieter Timmermans and colleagues review the pharmacology and the course of events that led to the identification of the lead compound and clinical candidate DuP753. Nonpeptide angiotensin II receptor antagonists represent novel therapeutic agents and are the preferred probes for exploring the (patho)physiological role(s) of angiotensin II. In addition, these compounds have provided evidence for the existence of different binding sites/receptors for angiotensin II.


Mar 27, 1975·The New England Journal of Medicine·D H StreetenT G Dalakos
Jul 1, 1990·Hypertension·P CorvolJ Ménard
Sep 21, 1990·European Journal of Pharmacology·B P RoweR C Speth
Sep 1, 1990·Brain Research Bulletin·J K WamsleyM Hunt
Nov 30, 1989·Biochemical and Biophysical Research Communications·A T ChiuA L Johnson
Oct 24, 1989·European Journal of Pharmacology·A T ChiuA L Johnson
May 1, 1989·Hypertension·P C WongP B Timmermans
Sep 1, 1989·Medical Toxicology and Adverse Drug Experience·B R Lindgren, R G Andersson
Aug 30, 1989·Biochemical and Biophysical Research Communications·S WhitebreadM de Gasparo
Nov 15, 1988·European Journal of Pharmacology·A T ChiuP B Timmermans
Dec 1, 1971·Circulation Research·D T PalsG S Denning

❮ Previous
Next ❯


Feb 1, 1996·Biopolymers·Y A Shin, S E Yoo
Jul 3, 2010·EMBO Molecular Medicine·Ariela BenigniGiuseppe Remuzzi
Nov 1, 1993·Journal of Clinical Pharmacology·R T EberhardtW H Frishman
Jan 1, 1996·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·M Peral de Bruno, A Coviello
Feb 9, 1994·Molecular and Cellular Biochemistry·N AiyarD J Bergsma
Aug 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·P Vermeij
May 1, 1996·Journal of Biomedical Science·C.C.H. YangJ.Y.H. Chan
Jan 1, 1994·European Journal of Clinical Pharmacology·P MüllerH Howald
Oct 1, 1996·In Vitro Cellular & Developmental Biology. Animal·N ShalitinG Kessler-Icekson
Jul 21, 1992·European Journal of Pharmacology·J ZhangJ C Van Meel
Jan 19, 1993·European Journal of Pharmacology·J M BarnesN M Barnes
Dec 12, 1994·European Journal of Pharmacology·S G BernierG Guillemette
Jul 4, 1995·European Journal of Pharmacology·K L ClarkG M Drew
Dec 4, 1995·European Journal of Pharmacology·T NakaharaK Nakayama
Jan 1, 1994·Neuroscience and Biobehavioral Reviews·J W Wright, J W Harding
Nov 1, 1992·Pharmacology & Therapeutics·J M Hall
Feb 1, 1995·Pharmacology & Therapeutics·J R CockcroftD J Webb
Sep 1, 1992·Brain Research. Brain Research Reviews·J W Wright, J W Harding
Jul 1, 1991·Trends in Pharmacological Sciences·P R Saxena, A J Man in 't Veld
Aug 1, 1991·Trends in Pharmacological Sciences·K Catt, A Abbott
Oct 1, 1994·Trends in Pharmacological Sciences·M J RobertsonP Leff
Mar 19, 1993·Regulatory Peptides·G P AldredF A Mendelsohn
Jul 23, 1993·Regulatory Peptides·B BunnemannD Ganten
Jun 11, 1993·Regulatory Peptides·D RegoliN E Rhaleb

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.